Hester Biosciences Limited

NSEI:HESTERBIO 株式レポート

時価総額:₹21.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Hester Biosciences 過去の業績

過去 基準チェック /16

Hester Biosciencesの収益は年間平均-9.8%の割合で減少していますが、 Biotechs業界の収益は年間 増加しています。収益は年間12% 12%割合で 増加しています。 Hester Biosciencesの自己資本利益率は7%であり、純利益率は6%です。

主要情報

-9.8%

収益成長率

-8.9%

EPS成長率

Biotechs 業界の成長5.1%
収益成長率12.0%
株主資本利益率7.0%
ネット・マージン6.0%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Jun 12
Revenues Working Against Hester Biosciences Limited's (NSE:HESTERBIO) Share Price

Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Aug 01
Hester Biosciences (NSE:HESTERBIO) Has Announced A Dividend Of ₹10.00

Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Mar 03
Would Hester Biosciences Limited (NSE:HESTERBIO) Be Valuable To Income Investors?

Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

Feb 13
Did You Miss Hester Biosciences' (NSE:HESTERBIO) Whopping 308% Share Price Gain?

What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

Jan 26
What Is The Ownership Structure Like For Hester Biosciences Limited (NSE:HESTERBIO)?

Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Jan 11
Who Has Been Buying Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 25
Hester Biosciences Limited's (NSE:HESTERBIO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Hester Biosciences's (NSE:HESTERBIO) Statutory Earnings A Good Guide To Its Underlying Profitability?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Nov 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

Nov 10
How Does Hester Biosciences Limited (NSE:HESTERBIO) Fare As A Dividend Stock?

If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

Oct 26
If You Had Bought Hester Biosciences (NSE:HESTERBIO) Shares Five Years Ago You'd Have Earned 212% Returns

What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Oct 05
What Type Of Shareholders Own The Most Number of Hester Biosciences Limited (NSE:HESTERBIO) Shares?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

Sep 14
Are Strong Financial Prospects The Force That Is Driving The Momentum In Hester Biosciences Limited's NSE:HESTERBIO) Stock?

These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

Aug 25
These 4 Measures Indicate That Hester Biosciences (NSE:HESTERBIO) Is Using Debt Extensively

How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

Aug 07
How Much Are Hester Biosciences Limited (NSE:HESTERBIO) Insiders Taking Off The Table?

Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

Jul 07
Hester Biosciences Limited (NSE:HESTERBIO) Is Yielding 0.5% - But Is It A Buy?

収支内訳

Hester Biosciences の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NSEI:HESTERBIO 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
31 Mar 243,1521896410
31 Dec 232,9921857400
30 Sep 233,1062577300
30 Jun 233,1642856020
31 Mar 232,7822666750
31 Dec 222,7232986210
30 Sep 222,5142715810
30 Jun 222,3793085410
31 Mar 222,4663935360
31 Dec 212,5044135190
30 Sep 212,5014515200
30 Jun 212,3974124930
31 Mar 212,1773444470
31 Dec 201,9892754030
30 Sep 201,9172673970
30 Jun 201,8482654060
31 Mar 201,8782925380
31 Dec 191,9563963640
30 Sep 191,9064093340
30 Jun 191,8904133080
31 Mar 191,8424162890
31 Mar 181,3732562440
31 Mar 171,2322351890
31 Mar 161,0091921560
31 Mar 159001361350
31 Mar 146909520313

質の高い収益: HESTERBIOは 高品質の収益 を持っています。

利益率の向上: HESTERBIOの現在の純利益率 (6%)は、昨年(9.6%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: HESTERBIOの収益は過去 5 年間で年間9.8%減少しました。

成長の加速: HESTERBIOは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: HESTERBIOは過去 1 年間で収益成長率がマイナス ( -29.1% ) となったため、 Biotechs業界平均 ( -3.2% ) と比較することが困難です。


株主資本利益率

高いROE: HESTERBIOの 自己資本利益率 ( 7% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘